종양 절제 시장 : 규모, 점유율, 성장 분석, 절제 유형별, 절차 유형별, 용도별, 최종 사용자별, 지역별 - 산업예측(2025-2032년)
Oncology Ablation Market Size, Share, Growth Analysis, By Type of Ablation (Radiofrequency Ablation, Microwave Ablation ), By Procedure Type, By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1623951
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 225 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 종양 절제 시장 규모는 2023년 13억 2,000만 달러로 평가되었습니다. 2024년 15억 달러에서 2032년에는 41억 6,000만 달러로 확대되었으며 예측 기간(2025-2032년) CAGR은 13.6%를 나타낼 전망입니다.
치료 옵션 시장은 보다 안전한 대체 치료에 대한 필요성 증가와, 특히 저소득 국가에서의 암 이환율 증가에 의해 크게 성장할 전망이며, 고소득 지역의 41%에 비해 80% 이상 급증이 예상됩니다. 최소 침습 및 비침습 치료에 대한 지향성 증가는 시장 확대를 더욱 강화할 것으로 예측됩니다. 첨단 종양 절제술은 외과의사와 환자 모두에게 회복 시간의 단축과 편안함의 향상에 의해 뒷받침됩니다. 외래 환자를 대상으로 하는 이러한 접근법은 전통적인 치료에 비해 전체 의료 비용을 절감합니다. 또한 절제 수술은 종양이 작은 경우에 선호되는 옵션이 되고 있으며, 연간 암 검진률이 수술 건수에 간접적으로 영향을 미치는 것이 부각되고 있습니다.
목차
서문
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
특허 분석
사례 연구
세계의 종양 절제 시장 규모 : 절제 유형별
시장 개요
고주파 절제(RFA)
마이크로파 절제(MWA)
레이저 절제
동결요법
비가역적 전기 천공(IRE)
고강도 초점식 초음파(HIFU)
기타
세계의 종양 절제 시장 규모 : 절차 유형별
시장 개요
최소 침습 절제
외과적 절제
세계의 종양 절제 시장 규모 : 용도별
시장 개요
간암
폐암
신장암
유방암
전립선암
뼈암
기타
세계의 종양 절제 시장 규모 : 최종 사용자별
시장 개요
병원
암 연구기관
전문 클리닉
외래수술센터(ASC)
세계의 종양 절제 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년 대비 비교(2022-2024년)
주요 기업 프로파일
Angiodynamics(Covidien)(US)
Boston Scientific Corporation(US)
Medtronic Plc(US)
Ethicon, Inc.(US)
Galil Medical Inc.(US)
Misonix Inc.(US)
HealthTronics(US)
Mermaid Medical(Denmark)
Theraclion(France)
Chongqing Haifu Medical Technology Co., Ltd.(China)
HS Hospital Service SPA(Italy)
Hologic, Inc.(US)
Varian Medical Systems(US)
Cook Medical(US)
LeVeen Medical(US)
Integra LifeSciences(US)
MedWaves, Inc.(US)
Sanarus Technologies, Inc.(US)
Bovie Medical Corporation(US)
ThermoLife(US)
결론과 권장사항
KTH
영문 목차
영문목차
Global Oncology Ablation Market size was valued at USD 1.32 billion in 2023 and is poised to grow from USD 1.5 billion in 2024 to USD 4.16 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).
The market for therapeutic options is poised for significant growth driven by the escalating need for safer treatment alternatives and the increasing incidence of cancer, especially in low-income countries where cases are projected to surge by over 80%, compared to 41% in high-income regions. The growing inclination toward minimally invasive and non-invasive procedures is expected to further boost market expansion. Advanced tumor ablation techniques are gaining traction as both surgeons and patients favor these methods for their quick recovery times and enhanced comfort. Characterized as outpatient procedures, these techniques reduce overall healthcare costs compared to conventional treatments. Additionally, ablative surgery is becoming the preferred option for smaller tumors, highlighting the indirect influence of annual cancer screening rates on procedural volume.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oncology Ablation Market Segmental Analysis
Global Oncology Ablation Market is segmented by Type of Ablation, Procedure Type, Application, End User and region. Based on Type of Ablation, the market is segmented into Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Laser Ablation, Cryoablation, Irreversible Electroporation (IRE), High-Intensity Focused Ultrasound (HIFU) and Others. Based on Procedure Type, the market is segmented into Minimally Invasive Ablation and Surgical Ablation. Based on Application, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Cancer and Others. Based on End User, the market is segmented into Hospitals, Cancer Research Institutes, Specialty Clinics and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Oncology Ablation Market
The global oncology ablation market is experiencing a significant boost in demand for advanced tumor ablation techniques, which is expected to persist throughout the forecast period. This surge is largely attributed to the growing preference among both surgeons and patients for minimally invasive procedures. The advantages associated with these techniques, such as reduced recovery times, enhanced patient comfort, and faster return to normal activities, are increasingly influencing decisions in favor of oncological interventions. As awareness and acceptance of these benefits continue to rise, the oncology ablation market is poised for substantial growth, reflecting a broader trend towards innovative and less invasive treatment options.
Restraints in the Global Oncology Ablation Market
The Global Oncology Ablation market faces several constraints primarily due to the complexities associated with ablation treatments. While tumor ablation therapy is gaining traction as a viable option for various solid organ cancers, the intricacies involved in the procedures can be daunting. Common complications such as blood loss and injuries to the target organ pose significant risks, categorized according to their associated threats. These adverse effects not only jeopardize patient safety but also increase the hesitance surrounding the adoption of these procedures, ultimately hindering market growth and limiting the wider acceptance of oncology ablation therapies in clinical settings.
Market Trends of the Global Oncology Ablation Market
The Global Oncology Ablation market is witnessing a significant shift as cooled radiofrequency probes gain traction among healthcare providers aiming for improved treatment methods. Market players are prioritizing technological advancements that enhance the precision, portability, and affordability of ablation techniques. Innovations such as High-Intensity Focused Ultrasound (HIFU), cryoablation, and image-guided equipment are at the forefront of this evolution. Notably, the advent of cooled radiofrequency denervation techniques is emerging as a critical contributor to market growth, facilitating complete denervation of the sacroiliac joint to effectively manage pain. This trend highlights a progressive move towards more efficient and impactful cancer treatment solutions.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies
Global Oncology Ablation Market Size by Type of Ablation & CAGR (2025-2032)
Market Overview
Radiofrequency Ablation (RFA)
Microwave Ablation (MWA)
Laser Ablation
Cryoablation
Irreversible Electroporation (IRE)
High-Intensity Focused Ultrasound (HIFU)
Others
Global Oncology Ablation Market Size by Procedure Type & CAGR (2025-2032)
Market Overview
Minimally Invasive Ablation
Surgical Ablation
Global Oncology Ablation Market Size by Application & CAGR (2025-2032)
Market Overview
Liver Cancer
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Bone Cancer
Others
Global Oncology Ablation Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Cancer Research Institutes
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
Global Oncology Ablation Market Size & CAGR (2025-2032)
North America (Type of Ablation, Procedure Type, Application, End User)
US
Canada
Europe (Type of Ablation, Procedure Type, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type of Ablation, Procedure Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type of Ablation, Procedure Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type of Ablation, Procedure Type, Application, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Angiodynamics (Covidien) (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boston Scientific Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medtronic Plc (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Ethicon, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Galil Medical Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Misonix Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
HealthTronics (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Mermaid Medical (Denmark)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Theraclion (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Chongqing Haifu Medical Technology Co., Ltd. (China)
